SARS-CoV-2 Serological assay
DiAgam has developped a SARS-CoV-2 serological assay consisting in a PETIA Homogeneous immunoassay (Particle Enhanced Turibidimetric Immuno Assay) to be used on automatic biochemistry analysers.
This assay is calibrated with human IgG anti Spike S1 SARS-COV-2.
The SARS-CoV-2 serological assay is intended for the qualitative detection of total antibodies to SARS-CoV-2 in human serum or plasma.
The SARS-CoV-2 serological assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity.